Home/Filings/4/0001600620-25-000075
4//SEC Filing

Bailey Jeffrey Allen 4

Accession 0001600620-25-000075

CIK 0001600620other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 5:04 PM ET

Size

5.2 KB

Accession

0001600620-25-000075

Insider Transaction Report

Form 4
Period: 2025-05-16
Transactions
  • Award

    Director Stock Option (right to buy)

    2025-05-16+37,48537,485 total
    Exercise: $8.15Exp: 2035-05-16Common Shares (37,485 underlying)
Footnotes (1)
  • [F1]The options shall vest one year from date of grant.

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001500210

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:04 PM ET
Size
5.2 KB